In this study, we investigated the role of four MEK3 mutations found within an ALL cohort, including R65L and R67W localized near the ATP binding site and P11T and R26T residing in the amino-terminal domain [24]. The gene discussed is MAP2K3; the disease is acute lymphoblastic leukemia.